Today, January 10th, let’s explore three stocks with buy rank and strong momentum characteristics for investors to consider.
Immunocore Holdings PLC: A Biotech Giant Making Waves
Immunocore Holdings plc (IMCR) is a late-stage biotechnology company that has caught the attention of investors with its Zacks Rank #1. The company has witnessed its Zacks Consensus Estimate for current year earnings increase by an impressive 6.9% over the last 60 days, a feat that reflects a company in ascension. In the past three months, Immunocore’s stocks soared by a staggering 52%, outpacing the S&P 500’s modest 8.4% advance. With a Momentum Score of A, Immunocore stands out as a force to be reckoned with in its industry.
Catalyst Pharmaceuticals, Inc.: A Rising Star in Biopharma
Catalyst Pharmaceuticals, Inc. (CPRX) is a biopharmaceutical company that has garnered a Zacks Rank #1, signifying a strong buy recommendation. The company has seen the Zacks Consensus Estimate for its current year earnings surge by an impressive 25.7% over the past 60 days, reflecting an upward trajectory. With a 17.4% surge in the past three months, Catalyst’s stocks have been outperforming the broader market, which advanced by 8.4%. Catalyst possesses a Momentum Score of A, solidifying its position as a notable player in the biopharma realm.
Amprius Technologies, Inc.: Powering the Future with Lithium-ion Innovation
Amprius Technologies, Inc. (AMPX), an ultra-high energy density lithium-ion batteries company, boasts a Zacks Rank #1, making it a compelling pick for investors seeking momentum stocks. The company has witnessed an 8.5% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days, a notable achievement. With a commendable 11.5% surge in the past three months, outpacing the S&P 500’s 8.4% advance, Amprius showcases resilience and growth. Amprius holds a Momentum Score of A, firmly establishing its presence as a key player in the lithium-ion sector.
It’s a good time for investors to dive into momentum stocks. With these strong contenders, investors may find rewarding opportunities amidst market volatility.
Get the Full List
Dive into the full list of top-ranked stocks here.
For those looking to delve deeper into the Momentum score and how it is calculated, there’s no time like the present to enhance one’s investing prowess.
Experts have selected 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. These curated stocks are deemed “Most Likely for Early Price Pops.” Since 1988, the full list has outperformed the market, boasting an average annual gain of +24.0%. These hand-picked stocks deserve immediate attention from investors who seek rewarding opportunities in the stock market. Find out more here.
Stay updated with the latest recommendations from Zacks Investment Research. Download 7 Best Stocks for the Next 30 Days here.
For comprehensive stock analysis reports, free stock analysis reports are available for:
Catalyst Pharmaceuticals, Inc. (CPRX)
Immunocore Holdings PLC Sponsored ADR (IMCR)
Amprius Technologies, Inc. (AMPX)
Read more insightful articles from Zacks.com here.
Get ready to navigate the stock market with Zacks Investment Research.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.